Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-28

Clinical Trial Update: A Study to Test the Effect of Cyclosporine on the Immune System of Patients With Early HIV Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of cyclosporine on the immune system in patients with early HIV disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED